ESC Premium Access

Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

Event: ESC Congress 2018
Topic: Cardiovascular Pharmacotherapy
Session type: Expert Session
Date: 26 August 2018
Time: 11:00 - 12:30

Congress Session

6 presentations in this session

Safety first: avoiding adverse events with new cardiovascular drugs - Panel

Thumbnail

Introduction - Safety first: avoiding adverse events with new cardiovascular drugs

Speaker: Doctor M. Alonso Garcia (London, GB)
Thumbnail

Scenario 1 - Adverse events of new lipid lowering drugs.

Speaker: Doctor T. Hall (Oslo, NO)
Thumbnail

Scenario 2 - Neprilysin inhibitors in heart failure: safety and adverse events

Speaker: Assistant Professor M. Kaluzna-Oleksy (Poznan, PL)
Thumbnail

Scenario 3 - Long-term safety of new anti-diabetic drugs.

Speaker: Associate Professor A. Niessner (Vienna, AT)
Thumbnail

Safety first: avoiding adverse events with new cardiovascular drugs - Take Home Message.

Speaker: Professor J. Tamargo (Madrid, ES)
Thumbnail

5 speakers from this session

Doctor Maria Angeles Alonso Garcia

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Trygve Sundby Hall

Oslo University Hospital Ulleval, Oslo (Norway)
4 presentations
0 follower

Assistant Professor Marta Izabela Kaluzna-Oleksy

Poznan University of Medical Sciences, Poznan (Poland)
4 presentations
0 follower

Associate Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)
6 presentations
0 follower

Professor Juan Luis Tamargo

Complutense University of Madrid, Madrid (Spain)
8 presentations
2 followers

This platform is supported by

logo Novo Nordisk